TABLE 1.
Clinical characteristics of SARS‐CoV‐2 virus infection by age group
| Clinical characteristics | Total (n = 376) | Age group (years) | P value | Vaccination status | P value | |||
|---|---|---|---|---|---|---|---|---|
| <3 (n = 104) | 3–5 (n = 94) | 6–17 (n = 178) | Unvaccinated (n = 250) | 2‐dose vaccination (n = 110) | ||||
| Asymptomatic cases, n (%) | 119 (31.6%) | 14 (13.5%) | 29 (30.9%) | 76 (42.7%) | <0.001 | 57 (22.8%) | 55 (50.0%) | <0.001 |
| Symptomatic cases, n (%) | 257 (68.4%) | 90 (86.5%) | 65 (69.1%) | 102 (57.3%) | <0.001 | 193 (77.2%) | 55 (50.0%) | <0.001 |
| Febrile cases, n (%) | 216 (57.4%) | 44 (42.3%) | 59 (62.8%) | 80 (44.9%) | 0.006 | 163 (65.2%) | 46 (41.8%) | <0.001 |
| Fever spike (°C), mean ± SD | 38.9 ± 0.6 | 39.0 ± 0.7 | 39.0 ± 0.6 | 38.8 ± 0.6 | 0.064 | 38.9 ± 0.6 | 38.8 ± 0.7 | 0.27 |
| Fever duration (days), mean ± SD | 1.7 ± 0.8 | 1.7 ± 0.9 | 1.6 ± 0.6 | 1.8 ± 0.8 | 0.45 | 1.6 ± 0.8 | 1.9 ± 0.9 | 0.19 |